Dear Colleagues,

How do you analyze the availability of drug care?

In the Russian Federation, accessibility analysis is usually based on two components:

1. Content analysis of the State Register of Medicines. All medicines registered in the country may be available to patients in any hospital. However, this method alone is not enough, since

A) Some expensive drugs may have low hospital margins.

B) Generic policies, procurement under an international name may have an impact on the availability of expensive branded drugs.

2. In-depth interviews, work with focus groups. Ask patients, doctors, experts - about the availability of certain drugs.

How do you determine the availability of medicines in your country? What methods are used?

More Dmitriy Ivanov's questions See All
Similar questions and discussions